These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22921523)

  • 21. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
    Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
    J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.
    Kaushal N; Robson MJ; Vinnakota H; Narayanan S; Avery BA; McCurdy CR; Matsumoto RR
    AAPS J; 2011 Sep; 13(3):336-46. PubMed ID: 21494909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain.
    Yu J; Cadet JL; Angulo JA
    J Neurochem; 2002 Nov; 83(3):613-22. PubMed ID: 12390523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine.
    Ren Q; Zhang JC; Ma M; Fujita Y; Wu J; Hashimoto K
    Psychopharmacology (Berl); 2014 Jan; 231(1):159-66. PubMed ID: 23934209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.
    Baladi MG; Newman AH; Nielsen SM; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2014 Jun; 732():105-10. PubMed ID: 24685638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
    Tata DA; Raudensky J; Yamamoto BK
    Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL; Darvesh AS
    Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red wine but not ethanol at low doses can protect against the toxicity of methamphetamine.
    Ali SF; Bondy SC
    Brain Res; 2010 Jul; 1346():247-50. PubMed ID: 20510887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
    Frey K; Kilbourn M; Robinson T
    Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity.
    Battaglia G; Fornai F; Busceti CL; Lembo G; Nicoletti F; De Blasi A
    J Neurochem; 2003 Jul; 86(2):413-21. PubMed ID: 12871582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
    Kawasaki T; Ishihara K; Ago Y; Nakamura S; Itoh S; Baba A; Matsuda T
    Eur J Pharmacol; 2006 Aug; 542(1-3):92-9. PubMed ID: 16784740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y; Martin JL; Ali SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
    Itzhak Y; Martin JL; Black MD; Ali SF
    Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.
    Seminerio MJ; Robson MJ; Abdelazeem AH; Mesangeau C; Jamalapuram S; Avery BA; McCurdy CR; Matsumoto RR
    AAPS J; 2012 Mar; 14(1):43-51. PubMed ID: 22183188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.
    Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA
    J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.